Sunday 25 February 2018

Couperin vs Springer and Elsevier: towards less extortionate deals?

Historically, the French consortium Couperin has obtained poor results in negotiating with predatory publishers, mostly consenting to their high and increasing prices. This is not necessarily Couperin’s fault, although it does not help that Couperin’s leadership appears weak and ill-informed. Rather, this is a consequence of the basic economics of scientific publishing, with publishers systematically abusing their strong position. Even the Finnish consortium FinELib, which was determined to seek a good deal and enjoyed a fair amount of support from researchers, recently consented to one more extortionate deal with Elsevier.

However, recent developments suggest that Couperin could fare better in current and upcoming negotiations: